Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Compound Lisinopril Tablets
NCT04885660Phase 1Completed
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Oct 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lisinopril and Levamlodipine in hypertension (HTN) (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Peak Plasma Concentration at 90 days. Started Oct 2018; status: completed.
02
Drugs
lisinoprilLevamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04885660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04885660.